|
HSP's EPS Net Growth by Quarter and Year
Hospira,'s EPS Net results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| HSP EPS Net (in $) |
FY 2014 |
FY 2013 |
FY 2012 |
FY 2011 |
| IV Quarter |
December |
-
|
0.20
|
0.03
|
-1.30
|
| III Quarter |
September |
0.92
|
0.01
|
0.01
|
-0.54
|
| II Quarter |
June |
0.42
|
0.20
|
-0.02
|
0.85
|
| I Quarter |
March |
0.40
|
-0.46
|
0.24
|
0.88
|
| FY |
|
1.74
|
-0.05
|
0.26
|
-0.11
|
| HSP EPS Net third quarter 2014 Y/Y Growth Comment |
HOSPIRA, INC. achieved in the third quarter 2014, above Company average EPS Net surge of 9100% year on year, to $ 0.92 .
Looking into third quarter 2014 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS Net growth. While Hospira, Inc.' s EPS Net doubling of 9100% ranks overall at the positon no. 99 in the third quarter 2014.
|
| HSP EPS Net ( Y/Y Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
566.67 % |
- |
- |
| III Quarter |
September |
9100 % |
0 % |
- |
- |
| II Quarter |
June |
110 % |
- |
- |
73.47 % |
| I Quarter |
March |
- |
- |
-72.73 % |
4.76 % |
| FY |
|
- |
- |
- |
- |
HSP EPS Net (Quarter on Quarter Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
1900 % |
200 % |
- |
| III Quarter |
September |
119.05 % |
-95 % |
- |
- |
| II Quarter |
June |
5 % |
- |
- |
-3.41 % |
| I Quarter |
March |
100 % |
- |
- |
144.44 % |
| FY (Year on Year) |
|
- |
- |
- |
- |
| EPS Net Y/Y Growth Statistics |
| High |
Average |
Low |
| 88.35 % |
6.26 % |
-45.95 % |
| (Sep. 30, 2014) |
|
(March 31, 2007) |
|
|
| EPS Net Y/Y Growth Statistics |
| High |
Average |
Low |
| 88.35 % |
6.26 % |
-45.95 % |
| (Sep. 30, 2014) |
|
(March 31, 2007) |
|
| EPS Net by Quarter for the Fiscal Years 2011, 2012, 2013, 2014 |
Hospira,'s Q/Q EPS Net Growth
| EPS Net Q/Q Growth Statistics |
| High |
Average |
Low |
| 1900 % |
87.08 % |
-95 % |
| (Dec 31 2013) |
|
(Sep. 30, 2013) |
| HSP's III. Quarter Q/Q EPS Net Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential EPS Net doubling of 119.05%, to $ 0.92 , from $0.42 in the second quarter.
Hospira, is going from strength to strength, with recording above normal gain, and also increasing rate, Amanda I. Clark, a business insider said.
Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher EPS Net quarter on quarter growth. While Hospira,'s EPS Net growth quarter on quarter, overall rank is 249. |
|
|
|
| EPS Net Q/Q Growth Statistics |
| High |
Average |
Low |
| 1900 % |
87.08 % |
-95 % |
| (Dec 31 2013) |
|
(Sep. 30, 2013) |
| HSP's III. Quarter Q/Q EPS Net Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 above company average sequential EPS Net doubling of 119.05%, to $ 0.92 , from $0.42 in the second quarter.
Hospira, is undergoing a remarkable growth, not only reporting higher then normal gain, and also accelerating speed.
Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher EPS Net quarter on quarter growth. While Hospira,'s EPS Net growth quarter on quarter, overall rank is 249. |
|
Hospira,'s 12 Months EPS Net Growth Year on Year
EPS Net TTM Growth |
12 Months Ending
(Sep. 30, 2014) |
12 Months Ending
(June 30. 2014) |
12 Months Ending
(March 31, 2014) |
12 Months Ending
(Dec 31 2013) |
12 Months Ending
(Sep. 30, 2013) |
| Cumulative EPS Net 12 Months Ending |
$ 1.94 |
$ 1.03 |
$ 0.81 |
$ -0.05 |
$ -0.22 |
| Y / Y EPS Net Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year EPS Net Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential EPS Net Change (TTM) |
88.35 % |
27.16 % |
- |
- |
- |
| Seq. EPS Net Growth (TTM) Overall
Ranking |
# 98 |
# 128 |
# 99 |
# 0 |
# 0 |
| Cumulative EPS Net growth
Comment |
Hospira, saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 9100% year on year, to $ 2 if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months EPS Net growth was higher than company's average 14.54% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest EPS Net growth, in Major Pharmaceutical Preparations industry.
But from twelve months ended June 30. 2014 increase was beneth at 88.35 % from $1.03 reported in twelve months ending a quarter June 30. 2014 Amanda I. Clark went on.
Yet this was evidence of positive momentum, while the average sequential EPS Net gain is at 6.26%.
The progress is even more impressive from the previous reporting period showed at 88.35 % jump from $1.03 in the period from June 30. 2014 to Sep. 30, 2013. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months EPS Net of $ 2 compare to EPS net loss of $ -0 a year ago.
Besides Major Pharmaceutical Preparations company has regained the bottom-line, the company by this time is improving fast with higher than usual EPS Net rise, from the period from June 30. 2014 to Sep. 30, 2013 of 88.35 % from $1.03 .
There is recovery on the way, although with caution, reporting below average 88.35 % EPS Net increase, from $1.03 from the twelve months ending in the quarter before.
HOSPIRA, INC. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. . |
| EPS Net TTM Q/Q Growth Statistics |
| High |
Average |
Low |
88.35 % |
6.26 % |
-45.95 % |
|
|
|
|
|
| EPS Net TTM Y/Y Growth Statistics |
| High |
Average |
Low |
167.65 % |
14.54 % |
-51.47 % |
| (Sep. 30, 2008) |
|
(Sep. 30, 2013) |
| EPS Net TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 3 |
| Sector |
# 5 |
| S&P 500 |
# 98 |
|
| Cumulative EPS Net growth
Comment |
Hospira, saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 9100% year on year, to $ 2 if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months EPS Net growth was higher than company's average 14.54% and higher than % growth in June 30. 2014. And, Hospira, realized the fastest EPS Net growth, in Major Pharmaceutical Preparations industry.
But sequential growth rate was beneth at 88.35 % from $1.03 recorded in the period from June 30. 2014 to Sep. 30, 2013.
Yet this was confirmation of positive momentum, while the usual Q/Q TTM gain lays at 6.26%.
The growth is even more impressive from the previous reporting period clinched at 88.35 % jump from $1.03 in the period from June 30. 2014 to Sep. 30, 2013. In the Sep. 30, 2014 period, Hospira, had cumulative twelve months EPS Net of $ 2 compare to EPS net loss of $ -0 a year ago.
Besides Hospira, has returned to prosperity, Hospira, by this time is gaining momentum and showing better then normal EPS Net surge, from the twelve months ending in the quarter June 30. 2014 of 88.35 % from $1.03 .
There is recovery on the way, but very slow one, reporting below usual 88.35 % EPS Net increase, from $1.03 from the twelve months ending in the quarter before Amanda I. Clark said.
HOSPIRA, INC. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. . |
| EPS Net TTM Q/Q Growth Statistics |
| High |
Average |
Low |
88.35 % |
6.26 % |
-45.95 % |
|
|
|
| EPS Net TTM Y/Y Growth Statistics |
| High |
Average |
Low |
167.65 % |
14.54 % |
-51.47 % |
| (Sep. 30, 2008) |
|
(Sep. 30, 2013) |
| EPS Net TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 3 |
| Sector |
# 5 |
| S&P 500 |
# 98 |
| Companies with similar EPS Net doubling for the quarter ending Sep. 30, 2014 within Healthcare Sector | Y/Y Change % | EPS Net for the quarter ending Sep. 30, 2014 | | HOSPIRA, INC. |  9,100.00% | $ 9,100.000 |
|
